Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies
International Journal of Molecular Sciences · 08.05.2024 · 25 (10) · 5117
DOI: 10.3390/ijms25105117 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.05.2024. Verfasst von Kylie Heitman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingha…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Muscle, Skeletal, Sarcopenia. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 523 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Chronic kidney disease (CKD) is associated with significant reductions in lean body mass and in the mass of various tissues, including skeletal muscle, which causes fatigue and contributes to high mortality rates. In CKD, the cellular protein turnover is imbalanced, with protein degradation outweighing protein synthesis, leading to a loss of protein and cell mass, which impairs tissue function. As CKD itself, skeletal muscle wasting, or sarcopenia, can have various origins and causes, and both CKD and sarcopenia share common risk factors, such as diabetes, obesity, and age. While these pathologies together with reduced physical performance and malnutrition contribute to muscle loss, they cannot explain all features of CKD-associated sarcopenia. Metabolic acidosis, systemic inflammation, insulin resistance and the accumulation of uremic toxins have been identified as additional factors that occur in CKD and that can contribute to sarcopenia. Here, we discuss the elevation of systemic phosphate levels, also called hyperphosphatemia, and the imbalance in the endocrine regulators of phosphate metabolism as another CKD-associated pathology that can directly and indirectly harm skeletal muscle tissue. To identify causes, affected cell types, and the mechanisms of sarcopenia and thereby novel targets for therapeutic interventions, it is important to first characterize the precise pathologic changes on molecular, cellular, and histologic levels, and to do so in CKD patients as well as in animal models of CKD, which we describe here in detail. We also discuss the currently known pathomechanisms and therapeutic approaches of CKD-associated sarcopenia, as well as the effects of hyperphosphatemia and the novel drug targets it could provide to protect skeletal muscle in CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Division of Neurology, Department of Pediatrics, The University of Alabama at Birmingham and Children's of Alabama, Birmingham, AL 35294, USA.
- Center for Exercise Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Department of Genetics, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Civitan International Research Center, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
ORCID-Profile: Matthew S Alexander, Christian Faul
Förderung
- NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
- The National Institutes of Health
Zitieren
APA
Heitman, K., Alexander, M. S., & Faul, C. (2024). Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies. International Journal of Molecular Sciences, 25(10), 5117. https://doi.org/10.3390/ijms25105117
Vancouver
Heitman K, Alexander MS, Faul C. Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies. International Journal of Molecular Sciences. 2024;25(10):5117. doi:10.3390/ijms25105117
BibTeX
@article{Heitman2024,
author = {Heitman, Kylie and Alexander, Matthew S and Faul, Christian},
title = {Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {10},
pages = {5117},
doi = {10.3390/ijms25105117}
}
EUVIMED